WASHINGTON (Reuters) - The Obama administration on Wednesday asked an appeals court for an emergency stay that would lift the ban on federal funding of research involving human embryonic stem cells. U.S. District Judge Royce Lamberth last month ruled that the research violated U.S. law because it involved destroying ...More
CHICAGO (Reuters) - A new Alzheimer's compound kept toxic clumps from forming in the brains of mice, without causing side effects seen in similar drugs, U.S. researchers said on Wednesday. They said the drug changes the way an enzyme called gamma secretase works, without completely blocking it, an approach ...More
LONDON (Reuters) - Israeli scientists have found a significant link between taking cholesterol-lowering statin drugs like Lipitor or Crestor and a reduced risk of developing rheumatoid arthritis. Researchers who studied 1.8 million patients registered with the Maccabi Healthcare Services in Israel found that those who regularly used statins were 40 ...More
NEW YORK (Reuters Health) - A new study adds to evidence that infants and toddlers are not too young to develop nasal allergies, particularly if their parents have a history of the bothersome condition. In a study of more than 1,800 18-month-old children, French researchers found that 9 percent had ...More
NEW YORK (Reuters Health) - African Americans are known to have a higher rate of heart disease and stroke than whites, and a new study suggests that those excess risks emerge at a relatively young age. Using data from a government health study, researchers found that African Americans between the ages ...More
LONDON (Reuters) - Providing surgical treatment for people who are morbidly obese could save British taxpayer-funded health services and the wider economy hundreds of millions of pounds a year, leading surgeons said on Wednesday. In an economic impact assessment of obesity surgery, Britain's Royal College of Surgeons and the National ...More
NEW YORK (Reuters Health) - Good news for kids with treatment-resistant asthma: Their breathing troubles just might be treatable. Approximately one in every 10 kids in the U.S. has asthma. And about one in 20 has a severe form that doesn't respond to standard therapies. But after thoroughly evaluating ...More
CHICAGO (Reuters) - Drugmaker Wyeth used ghostwriters to play up the benefits and downplay the harm of hormone replacement therapy in articles published in medical journals, a U.S. researcher said on Tuesday. Dr. Adriane Fugh-Berman of Georgetown University Medical Center in Washington analyzed dozens of ghostwritten reviews and commentaries published ...More
